Cargando…
The impact of acute rosiglitazone on insulin pharmacokinetics at the blood‐brain barrier
INTRODUCTION: CNS insulin levels are decreased and insulin receptor signalling is dampened in Alzheimer's disease (AD). Increasing CNS insulin levels through a variety of methods has been shown to improve memory. Indeed, medications routinely used to improve insulin resistance in type 2 diabete...
Autores principales: | Galindo, Demi C., Banks, William A., Rhea, Elizabeth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375048/ https://www.ncbi.nlm.nih.gov/pubmed/32704569 http://dx.doi.org/10.1002/edm2.149 |
Ejemplares similares
-
Endocytosis of insulin at the blood-brain barrier
por: Pemberton, Sarah, et al.
Publicado: (2022) -
The Blood–Brain Barrier, Oxidative Stress, and Insulin Resistance
por: Banks, William A., et al.
Publicado: (2021) -
Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance
por: Rhea, Elizabeth M., et al.
Publicado: (2019) -
The Effects of Viruses on Insulin Sensitivity and Blood–Brain Barrier Function
por: Raber, Jacob, et al.
Publicado: (2023) -
Effects of Rapamycin on Insulin Brain Endothelial Cell Binding and Blood–Brain Barrier Transport
por: Nguyen, Steven, et al.
Publicado: (2021)